Chinese biopharma starts feeding the global pipeline

A handful of discovered-in-China candidates have entered the global clinic, including a few first-in-class contenders.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Biopharma investment in China.

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mullard, A. Chinese biopharma starts feeding the global pipeline. Nat Rev Drug Discov 16, 443–446 (2017).

Download citation

Further reading


Sign up for the Nature Briefing newsletter for a daily update on COVID-19 science.
Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing